The Ratio of CD226 and TIGIT Expression in Tfh and PD-1⁺ICOS⁺Tfh Cells Are Potential Biomarkers for Chronic Antibody-Mediated Rejection in Kidney Transplantation

Figure 5

ROC curves for diagnosis of CAMR. (a) ROC curve of PD-1⁺ICOS⁺Tfh cells. (b) ROC curve of CD226⁺Tfh cell/TIGIT⁺Tfh cell ratio. (c) ROC curve of eGFR. (d) Combination of CD226⁺Tfh cell/TIGIT⁺Tfh cell ratio and PD-1⁺ICOS⁺Tfh cells. (e) ROC curve of combination of CD226⁺Tfh cell/TIGIT⁺Tfh cell ratio, PD-1⁺ICOS⁺Tfh cells, and eGFR.

(a)

(b)

(c)

(d)

(e)